CaMKII and a failing strategy for growth in heart

Mark E. Anderson

doi:10.1172/jci39262

April 16, 2009Journal of Clinical InvestigationOpen Access

CaMKII and a failing strategy for growth in heart

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study aims to explore the role of CaMKII in the progression from myocardial hypertrophy to heart failure.
Examined the effects of CaMKII activation in a mouse model of cardiac dysfunction.
Analyzed cell signaling pathways associated with heart failure development.
Activation of CaMKII was shown to significantly increase heart failure incidence in the mouse model (exact metrics not provided).
Induced myocardial hypertrophy did not directly lead to heart failure without CaMKII activation.

Design

Editorial

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This commentary highlights the central role of CaMKII in the transition from myocardial hypertrophy to heart failure, discussing recent mouse model studies that suggest CaMKII inhibition as a potential therapeutic strategy.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mark E. Anderson (2009) studied this question.

synapsesocial.com/papers/6a6f947ce71d69abee0819e4 https://doi.org/10.1172/jci39262

View Full Paper

Ask AI

Bookmark

Share

CaMKII and a failing strategy for growth in heart

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

CaMKII and a failing strategy for growth in heart

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading